Candriam SCA’s Rigel Pharmaceuticals RIGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
|
|||||
|
2022
Q2 | $1.61M | Hold |
|
|||||
|
2022
Q1 | $4.27M | Sell |
|
|||||
|
2021
Q4 | $5.89M | Hold |
|
|||||
|
2021
Q3 | $8.06M | Hold |
|
|||||
|
2021
Q2 | $9.64M | Buy |
|
|||||
|
2020
Q4 | – | Sell |
|
|||||
|
2020
Q3 | $672K | Sell |
|
|||||
|
2020
Q2 | $3.56M | Sell |
|
|||||
|
2020
Q1 | $5.11M | Hold |
|
|||||
|
2019
Q4 | $5.23M | Sell |
|
|||||
|
2019
Q3 | $4.63M | Buy |
|
|||||
|
2019
Q2 | – | Sell |
|
|||||
|
2019
Q1 | $6.37M | Hold |
|
|||||
|
2018
Q4 | $5.7M | Buy |
|
|||||
|
2018
Q3 | $7.28M | Buy |
|
|||||
|
2018
Q2 | $4.44M | Buy |
|
|||||
|
2018
Q1 | $5.33M | Buy |
|
|||||
|
2017
Q4 | $4.73M | Sell |
|
|||||
|
2017
Q3 | $3.21M | Buy |
|
|||||
|
2017
Q2 | $3.22M | Buy |
|
|||||
|
2017
Q1 | $3.59M | Buy |
|
|||||
|
2016
Q4 | $1.46M | Sell |
|
|||||
|
2016
Q3 | $2.66M | Buy |
|